Z. Houiene et al. / Tetrahedron: Asymmetry 24 (2013) 290–296
295
5.6.2. (R)-(+)-1-(4-Methoxyphenyl) ethanol 2
GC (Chiralsil-Dex CB): tR = 12.7 min, tS = 13.5 min (Tcolumn
135 °C, flow 1.2 mL/min).
min; ½a 2D0
ꢃ
¼ ꢂ79:4 (c 0.2, CHCl3) for 90% ee, {Lit. [
a
]
D = ꢂ85.2 (c
=
=
2.4, CHCl3); 99% ee (S)}.13a
5.6.17. (S)-(ꢂ)-2,3-Dihydro-1H-inden-yl acetate 8a
5.6.3. (R)-(+)-1-(4-Ethoxyphenyl) ethanol 3
GC (Chiralsil-Dex CB): tR = 13.1 min, tS = 13.9 min (Tcolumn
155 °C, flow 1.2 mL/min).
GC (Chiralsil-Dex CB): tS = 46.1 min, tR = 46.9 min (Tcolumn =
80 °C for 7 min, after 135 °C for 5 min, flow 1.2 mL/min). ½a D20
ꢃ
ꢂ100 (c 0.5, CHCl3) for 90% ee, {Lit. [
a]D = +85 (c 1, CHCl3) for
80% ee (R)}.17
5.6.4. (R)-(+)-1-(Naphthalene-1-yl) ethanol 4
Chiral HPLC: Chiracel OD-H column, tR = 20.05 min,
tS = 28.90 min. Eluant (v,v): hexane/i-PrOH: 90/10; flow 0.5 mL/min.
5.6.18. (S)-(ꢂ)-1,2,3,4-Tetrahydronaphthalen-1-yl acetate 9a
GC (Chiralsil-Dex CB): tR = 57.4 min, tS = 58.6 min (Tcolumn
80 °C for 7 min, after 135 °C for 5 min, flow 1.2 mL/min).
=
5.6.5. (R)-(+)-1-(2-Naphthyl) ethanol 5
½
a 2D0
ꢃ
¼ ꢂ97:5 (c 0.5, CHCl3) for 90% ee, {Lit. [
a]D = +105 (c 1, CHCl3)
GC (Chiralsil-Dex CB): tR = 10.2 min, tS = 10.5 min (Tcolumn
170 °C, flow 1.2 mL/min).
=
=
for 92% ee (R)}.17
Acknowledgments
5.6.6. (R)-(+)-1-(6-Methoxynaphthalen-2-yl) ethanol 6
GC (Chiralsil-Dex CB): tR = 17.2 min, tS = 17.7 min (Tcolumn
180 °C, flow 1.2 mL/min).
Algerian Ministry of education and scientific research (FNR
2000 and PNR), Université catholique de Louvain and FNRS are
gratefully acknowledged for their financial support of this work.
5.6.7. (R)-(ꢂ)-Acenaphthenol 7
Chiral HPLC: Chiracel OD-H column, tR = 28.80 min,
tS = 34.67 min. Eluant (v,v): hexane/i-PrOH: 95/5; flow 0.5 mL/min.
References
1. (a) Kirchner, G.; Scollar, M. P.; Klibanov, A. M. J. Am. Chem. Soc. 1985, 107, 7072–
7076; (b) Klibanov, A. M. CHEMTECH 1986, 16, 354–359; (c) Klibanov, A. M. J.
Am. Chem. Soc. 1986, 108, 2767–2768; (d) Faber, K.; Riva, S. J. Synth. Org. Chem.
1992, 895–910; (e) Zhu, B.; Panek, J. S. Org. Lett. 2000, 2, 2575–2578; (f) Reetz,
M. T. Curr. Opin. Chem. Biol. 2002, 6, 145–150; (g) Pavel, R. N. Curr. Opin. Drug
Disc. Dev. 2003, 6, 902–920; (h) Faber, K. Biotransformations in Organic
Chemistry, 6th ed.; Springer-Verlag: Berlin Heidelberg, 2011; (i) Ahmed, M.;
Kelly, T.; Ghanem, A. Tetrahedron 2012, 68, 6781–6802.
2. (a) Trost, B. M. Science 1991, 1471–1477. Angew. Chem., Int. Ed. 1995, 107, 285–
307: Trost, B.M. Angew. Chem., Int. Ed. 1995, 34, 259–281; (b) Anastas, P. T.;
Warner, J. C. Green Chemistry: Theory and Practice; Oxford University Press: New
York, 1998; (c) Anastas, P. T.; Li, P. T. Water as a Green Solvent; John Wiley &
Sons, 2010; (d) Anastas, P. T.; Eghbali, N. Chem. Soc. Rev. 2010, 39, 301–312.
3. (a) Carrera, G.; Riva, S. Angew. Chem., Int. Ed. 2000, 39, 2227–2254; (b) Ghanem,
A. Tetrahedron 2007, 63, 1721–1754; (c) Merabet-Khellassi, M.; Aribi-
Zouioueche, L.; Riant, O. Tetrahedron: Asymmetry 2009, 20, 1371–2377; (d)
Chênevert, R.; Pelchet, N.; Morin, P. Tetrahedron: Asymmetry 2009, 20, 1191–
1196; (e) Merabet-Khelassi, M.; Bouzemi, N.; Fiaud, J.-C.; Riant, O.; Aribi-
Zouioueche, L. C. R. Chim. 2011, 14, 978–986.
4. (a) Boland, W.; Frossl, C.; Lorenz, M. Synthesis 1991, 1049–1072; (b) Kawasaki,
M.; Nakamura, K.; Kawabata, S. J. Mol. Catal. B: Enzym. 1999, 6, 447–451; (c)
Kang, S.-K.; Jeon, J.-H.; Yamaguchi, T.; Kim, J.-S.; Ko, B.-S. Tetrahedron:
Asymmetry 1995, 6, 2139–2142; (d) Aoyagi, N.; Ogawa, N.; Izumi, T.
Tetrahedron Lett. 2006, 47, 4797–4801; (e) Reddipalli, G.; Venkataiah, M.;
Fadnavis, N. W. Tetrahedron: Asymmetry 2010, 21, 320–324; (f) Bora, P. P.; Bez,
G.; Anal, J. M. H. J. Mol. Catal. B: Enzym. 2011, 72, 270–275.
5. (a) Stercher, H.; Faber, K. Synthesis 1997, 1–16; (b) Strauss, U. T.; Felfer, U. F.;
Faber, K. Tetrahedron: Asymmetry 1999, 10, 107–117; (c) Faber, K. Chem. Eur. J.
2001, 7, 5005–5010; (d) Turner, N. J. Curr. Opin. Biotechnol. 2003, 14, 401–406;
(e) Pàmies, O.; Bäckvall, J.-E. Curr. Opin. Biotechnol 2003, 14, 407–413; (f)
Matute, B. M.; Bäckvall, J.-E. Curr. Opin. Chem. Biol. 2007, 11, 226–232; (g)
Kamal, A.; Azhar, M. A.; Krishnaji, T.; Malik, M. H.; Azeeza, S. Coord. Chem. Rev.
2008, 569–592; (h) Merabet-Khelassi, M.; Vriamont, N.; Riant, O.; Aribi-
Zouioueche, L. Tetrahedron: Asymmetry 2011, 22, 1790–1796; (i) Pellissier, H.
Tetrahedron 2011, 67, 3769–3802.
6. (a) van den Heuvel, M.; Cuiper, A. D.; van der Deen, H.; Kellogg, R. M.; Feringa,
B. L. Tetrahedron Lett. 1997, 38, 1655–1658; (b) El Ghihani, M. T.; Williams, J. M.
J. Curr. Opin. Chem. Biol. 1999, 3, 11–15.
7. (a) Takano, S.; Suzuki, M.; Ogasawara, K. Tetrahedron: Asymmetry 1993, 4,
1043–1046; (b) Vanttinen, E.; Kanerva, L. T. Tetrahedron: Asymmetry 1995, 6,
1779–1786; (c) Liu, H. L.; Anthonsen, T. Chirality 2002, 14, 25–27; (d) Wallner,
A.; Mang, H.; Glieck, S. M.; Steinreiber, A.; Mayer, S. F.; Faber, K. Tetrahedron:
Asymmetry 2003, 14, 2427–2432; (e) Bouzemi, N.; Aribi-Zouioueche, L.; Fiaud, J.
C. Tetrahedron: Asymmetry 2006, 17, 797–800.
8. (a) Voss, C. V.; Gruber, C. C.; Faber, K.; Knaus, T.; Macheroux, P.; Kroutil, W. J.
Am. Chem. Soc. 2008, 130, 13969–13972; (b) Mu, X. Q.; Xu, Y.; Yang, M.; Sun, Z.
H. Process Biochem. 2011, 46, 233–239.
9. Mitsunobu, O.; Yamada, M. Bull. Chem. Soc. Jpn. 1967, 40, 2380.
10. (a) Danda, T.; Nagatomi, T.; Maehara, A.; Umemura, T. Tetrahedron 1991, 47,
8701–8716; (b) Steinreiber, A.; Stadler, A.; Mayer, S. F.; Faber, K.; Kappe, O.
Tetrahedron Lett. 2001, 42, 6283–6286; (c) Shimada, Y.; Usuda, K.; Okabe, H.;
Suzuki, T.; Matsumoto, K. Tetrahedron: Asymmetry 2009, 20, 2802–2808.
11. Rakels, J. L. L.; Straathof, A. J. J.; Heijneii, J. J. Tetrahedron: Asymmetry 1994, 5,
93–100.
5.6.8. (R)-(ꢂ)-1-Indanol 8
GC (Chiralsil-Dex CB), tR = 51.2 min, tS = 51.9 min (Tcolumn
80 °C for 7 min, after 135 °C for 5 min, flow 1.2 mL/min).
=
=
5.6.9. (R)-(ꢂ)-1,2,3,4-Tetrahydronaphthalen-1-ol 9
GC (Chiralsil-Dex CB), tS = 63.7 min, tR = 65.0 min (Tcolumn
80 °C for 7 min, then 135 °C for 5 min, flow 1.2 mL/min).
5.6.10. (S)-(ꢂ)-1-(Phenylethyl) acetate 1a
GC (Chiralsil-Dex CB), tS = 2.9 min, tR = 3.2 min (Tcolumn = 140 °C,
flow 1.2 mL/min). ½a D20
¼ ꢂ136 (c 0.1, CHCl3) for 99% ee, {Lit.
ꢃ
[a]
D = +135.9 (c 1, CHCl3) for 99% ee (R)].17
5.6.11. (S)-(ꢂ)-1-(4-Methoxyphenyl)ethyl acetate 2a
GC (Chiralsil-Dex CB), tS = 10.9 min, tR = 12.1 min (Tcolumn
=
135 °C, flow 1.2 mL/min). ½a D20
ꢃ
¼ ꢂ8 (c 0.2, CHCl3) for 57% ee, {Lit.
[a]
D = +11.4 (c 1.2, CHCl3) for 84% ee (R)].17
5.6.12. (S)-(ꢂ)-1-(4-Ethoxyphenyl)ethyl acetate 3a
GC (Chiralsil-Dex CB), tS = 12.2 min, tR = 13.4 min (Tcolumn
=
155 °C, flow 1.2 mL/min). ½a D20
ꢃ
¼ ꢂ70:8 (c 0.5, CHCl3) for 60% ee,
{Lit. [
a]
D = ꢂ113.1 (c 0.9, CHCl3) for >85% ee (S)}.18
5.6.13. (S)-(ꢂ)-1-(Naphthalen-1-yl) ethyl acetate 4a
Chiral HPLC: Chiracel OD-H column, tR = 9.87 min,
tS = 13.50 min. Eluant (v,v): hexane/i-PrOH: 90/10; flow 0.5 mL/
min. ½a 2D0
ꢃ
¼ ꢂ46:5 (c 0.2, CHCl3) for 99% ee, {Lit. [
a]D = +49.5 (c 1,
CHCl3) for 99% ee (R)}.17
5.6.14. (S)-(ꢂ)-1-(Naphthalen-2-yl) ethyl acetate 5a
GC (Chiralsil-Dex CB), tS = 8.6 min, tR = 8.9 min (Tcolumn = 170 °C,
flow 1.2 mL/min). ½a D20
¼ ꢂ104 (c 0.2, CHCl3) for 92% ee, {Lit.
ꢃ
[a]
D = +110.2 (c 1, CHCl3) for 99% ee (R)}.17
5.6.15. (S)-(ꢂ)-1-(6-Methoxynaphthalen-2-yl) ethyl acetate 6a
GC (Chiralsil-Dex CB), tS = 16.2 min, tR = 16.6 min (Tcolumn
=
180 °C, flow 1.2 mL/min). ½a D20
¼ ꢂ64:5 (c 0.3, CHCl3) for 65% ee,
ꢃ
{Lit. [a]
D = +110 (c 1, EtOH) for 99% ee (R)}.17
5.6.16. (S)-(ꢂ)-1-Acenaphthyl acetate 7a
12. Merabet-Khelassi, M.; Houiene, Z.; Aribi-Zouioueche, L.; Riant, O. Tetrahedron:
Asymmetry 2012, 23, 823–833.
Chiral HPLC: Chiracel OD-H column. tS = 11.88 min,
tR = 12.52 min. Eluant (v,v): hexane/i-PrOH: 95/5; flow 0.5 mL/